High risk HPV load estimated by Hybrid Capture II® correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women

被引:39
作者
Prétet, JL
Dalstein, V
Monnier-Benoit, S
Delpeut, S
Mougin, C
机构
[1] Ctr Hosp Univ J Minjoz, EA3181, Biol Cellulaire & Mol Lab, F-25030 Besancon, France
[2] Ctr Hosp Univ J Minjoz, IFR 133, F-25030 Besancon, France
关键词
human papillomavirus; cervical cancer; viral load; HCII (R); real-time PCR;
D O I
10.1016/j.jcv.2004.02.008
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: High risk human papillomavirus (HR-HPV) load determined by quantitative methods has already been considered as highly predictive of future development of high grade cervical lesions. Some studies also demonstrated that Hybrid Capture II(R) (HCII(R)) results can be considered as a reflection of HPV DNA load, while others did not. HCII(R) assay, well suited for routine HR-HPV screening, is not especially dedicated for quantitative use. However, we have recently shown that women with high viral loads assessed by HCHO were at increased risk of cervical precancer. Objectives: The aim of the study was to determine if the values given by the HCHO assay can be considered as quantitative. Study design: We used a real-time PCR allowing precise quantification of both HPV 16 genome and albumin gene to normalize the measuring HPV 16 load in cervical cells and to compare the data with those obtained by HCHO in a series of 40 HR-HPV positive samples. Results: Reproducibility of the HPV 16 real-time PCR, assessed from nine independent experiments of serial dilutions of SiHa cell DNA, was reflected in coefficients of variation for standard curves of crossing point (Cp) values below 5%. The HPV16 loads with a broad individual variability were significantly related to the cumulative load estimated by HCII(R) and did not depend on the cellularity of samples. Conclusions: We assume that the HCII(R) values can be used as a quantitative measure of HR-HPV DNA, so long as cervical specimens are collected using standardized protocols. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:140 / 147
页数:8
相关论文
共 37 条
[1]   Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: A longitudinal study of 3,091 women [J].
Bory, JP ;
Cucherousset, J ;
Lorenzato, M ;
Gabriel, R ;
Quereux, C ;
Birembaut, P ;
Clavel, C .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (05) :519-525
[2]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[3]   Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women [J].
Clavel, C ;
Masure, L ;
Bory, JP ;
Putaud, I ;
Mangeonjean, C ;
Lorenzato, M ;
Nazeyrollas, P ;
Gabriel, R ;
Quereux, C ;
Birembaut, P .
BRITISH JOURNAL OF CANCER, 2001, 84 (12) :1616-1623
[4]   Management of women who test positive for high-risk types of human papillomavirus: the HART study [J].
Cuzick, J ;
Szarewski, A ;
Cubie, H ;
Hulman, G ;
Kitchener, H ;
Luesley, D ;
McGoogan, E ;
Menon, U ;
Terry, G ;
Edwards, R ;
Brooks, C ;
Desai, M ;
Gie, C ;
Ho, L ;
Jacobs, I ;
Pickles, C ;
Sasieni, P .
LANCET, 2003, 362 (9399) :1871-1876
[5]   HPV testing in primary screening of older women [J].
Cuzick, J ;
Beverley, E ;
Ho, L ;
Terry, G ;
Sapper, H ;
Mielzynska, I ;
Lorincz, A ;
Chan, WK ;
Krausz, T ;
Soutter, P .
BRITISH JOURNAL OF CANCER, 1999, 81 (03) :554-558
[6]   Persistence and load of high-risk hpv are predictors for development of high-grade cervical lesions:: A longitudinal French cohort study [J].
Dalstein, W ;
Riethmuller, D ;
Prétet, JL ;
Carval, KL ;
Sautière, JL ;
Carbillet, JP ;
Kantelip, B ;
Schaal, JP ;
Mougin, C .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (03) :396-403
[7]   Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia [J].
Elfgren, K ;
Jacobs, M ;
Walboomers, JMM ;
Meijer, CJLM ;
Dillner, J .
OBSTETRICS AND GYNECOLOGY, 2002, 100 (05) :965-971
[8]   HUMAN PAPILLOMAVIRUS DETECTION BY HYBRID CAPTURE AND ITS POSSIBLE CLINICAL USE [J].
FARTHING, A ;
MASTERSON, P ;
MASON, WP ;
VOUSDEN, KH .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (07) :649-652
[9]  
Gravitt PE, 2003, CANCER EPIDEM BIOMAR, V12, P477
[10]   PERSISTENT GENITAL HUMAN PAPILLOMAVIRUS INFECTION AS A RISK FACTOR FOR PERSISTENT CERVICAL DYSPLASIA [J].
HO, GYF ;
BURK, RD ;
KLEIN, S ;
KADISH, AS ;
CHANG, CJ ;
PALAN, P ;
BASU, J ;
TACHEZY, R ;
LEWIS, R ;
ROMNEY, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (18) :1365-1371